And that's just one leukaemia drug. India's generic industry has been producing many such life-saving medicines at a fraction of the global price... ...http://timesofindia.indiatimes.com/life-style/health-fitness/health-news/The-pill-that-costs-9000-in-US-sells-for-70-in-India/articleshow/50887471.cms
In a chat with , Porinju Veliyath, MD & Portfolio Manager, Equity Intelligence, says the time for casual buying is over. One has to be very... ...http://economictimes.indiatimes.com/markets/expert-view/there-is-huge-opportunity-for-stock-picking-in-the-market-porinju-veliyath-equity-intelligence/articleshow/50863065.cms
It's 8:00 am on a Sunday and outside Denzong Cinema in Gangtok's Lal Bazar, the otherwise languid atmosphere is punctured by grocers of two kinds.... ...http://economictimes.indiatimes.com/news/economy/agriculture/how-sikkim-could-offer-lessons-to-other-states-in-organic-farming/articleshow/50883232.cms
The Hyderabad-based Bharat Biotech might be the first to come out with a vaccine for the Zika virus if its efficacy can be proved. If it does... ...http://timesofindia.indiatimes.com/home/sunday-times/deep-focus/The-pill-that-costs-9000-in-US-sells-for-70-in-India/articleshow/50883406.cms
After the dismal performance of Tata Steel in the December quarter, the company's new plant at Kalinganagar has been placed under the lens.... ...http://smartinvestor.business-standard.com/market/Compnews-364532-Compnewsdet-Tata_Steels_poor_show_in_Dec_quarter_raises_concerns.htm
We would like to introduce our...